Statement on Cysteamine cream (Cyspera since 2016)

Statement of Dr Christophe Hsu MD [Memberships: Singapore Medical Association (SMA), Dermatological Society of Singapore (DSS), American Academy of Dermatology (AAD), Japanese Society for Investigative Dermatology (JSID)]

  • To answer recurrent questions of colleagues (among others) particularly in Singapore, Taiwan, the US and Japan, I have no financial interest nor any other interest in Scientis, which commercializes Cyspera (Cysteamine Cream).
  • I learnt from inner & outer sources that my name has been subsequently used as a marketing tool to dermatologists, plastic surgeons, medical doctors and other healthcare providers over time to sell this product to their patients. [uncompensated]
  • The collaboration was stopped by the Chairman of Scientis, after signing a non-partnership clause (May 2014) with the administrator of the a healthcare centre providing clinical services in dermatology which I cofounded. Until then the commercial price of Cysteamine Cream was $59.
  • For the sake of self-respect, the content presenting the product will remain online. Nevertheless this should not be interpreted as a form of endorsement in any way.
  • Presentation (please read note below): LINK
  • Communications (all self-funded):
    • National Skin Centre Update (NSC; Singapore; June 2012; Poster presentation)
    • American Academy of Dermatology (AAD; Miami-USA; March 2013; Oral and poster presentation)
    • European Academy of Dermatology and Venereology Annual Meeting (EADV; Prague-Czech Republic; September 2012; Poster presentation)
    • Asian Dermatology Congress (ADC; Hong-Kong SAR; July 2013; Oral presentation)
    • European Society for Pigment Cell Research (ESPCR; Geneva-Switzerland; September 2012; Poster presentation)

image description